Antithymocyte globulin and cyclosporin A are synergistic in an experimental transplantation tolerance model in the rat

Scandinavian Journal of Immunology

Volumn 49, Issue 1, 1999, Pages 38-44

  Olausson, Michael ^a   Lukes, D ^a   Norrby, J ^a   Qi, Z ^b   Ekberg, H ^c   Gannedahl, G ^c   Tufveson, G ^c   Mjornstedt L ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; ROQUINIMEX; THYMOCYTE ANTIBODY;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG POTENTIATION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEART GRAFT; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; TRANSPLANTATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTILYMPHOCYTE SERUM; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; DRUG ADMINISTRATION SCHEDULE; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; GRAFT SURVIVAL; HEART TRANSPLANTATION; HYDROXYQUINOLINES; IMMUNE TOLERANCE; INTUBATION, GASTROINTESTINAL; MALE; RATS; RATS, INBRED STRAINS;

EID: 0032893122     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1999.00453.x     Document Type: Article

References (41)

1. 1 Illner WD, Land W, Haberstetzer R et al. Cyclosporine in combination with azathioprine and steroids in cadaveric renal transplantation. Transplant Proc 1985;17:1181-4.
2. 2 Simmons RL, Canafax DM, Strand M et al. Management and prevention of cyclosporine nephrotoxicity after renal transplantation: use of low doses of cyclosporine, azathioprine and prednisolone. Transplant Proc 1985;17:266-9.
3. 3 Slapak M, Geoghegan T, Digard N, Ahmed K, Sharman VL, Crocket R. The use of low dose cyclosporine in combination with azathioprine and steroids in renal transplantation. Transplant Proc 1985; 17:1222-7.
4. 4 Azuma H, Binder J, Heeman U, Schmid C, Tullius SG, Tilney NL. Effects of RS61443 on functional and morphological changes in chronically rejecting rat kidney allografts. Transplantation 1995; 59:460-6.
5. 5 Lindholm A, Albrechtsen D, Tufveson G, Karlberg I, Persson NH, Groth CG. A randomized trial of cyclosporine and prednisolone versus cyclosporine, azathioprine and prednisolone in primary cadaveric renal transplantation. Transplantation 1992;54:624-31.
6. 6 Ponticelli C, Tarantino A, Motagnino G. A randomized trial comparing triple-drug and double-drug therapy in renal transplantation. Transplantation 1988;45:913-8.
7. 7 European Mycophenolate Mofetil Cooperative Study Group. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet 1995;345:1321-5.
8. 8 Canafax DM, Torres A, Fryd DS et al. The effects of delayed function on recipients of cadaver renal allografts. A study of 158 patients randomized to cyclosporine or ALG-azathioprine. Transplantation 1986;41:177-81.
9. 9 Talbot D, Reddy KS, Watson D et al. Developing the ideal immunosuppressive protocol by internal audit. Transpl Int 1995; 8:392-5.
10. 10 Abouna GM, Al-Abdullah IH, Kelly-Sullivan D etal. Randomized clinical trial of antithymocyte globulin induction in renal transplantation comparing a fixed daily dose with dose adjustment according to T cell monitoring. Transplantation 1995;59:1564-8.
11. 11 Bock HA, Gallati H, Zurcher RM et al. A randomized prospective trial of prophylactic immunosuppression with ATG-fresenius versus OKT3 after renal transplantation. Transplantation 1995;59:830-40.
12. 12 Olausson M. Characteristics of transplantation tolerance with special reference to the induction phase. Thesis, University of Göteborg 1986.
13. 13 Mjörnstedt L. Mechanisms in experimental transplantation. Thesis, University of Göteborg 1987.
14. 14 Olausson M, Wramner L, Kjellson B, Mjörnstedt L, Söderström T. Alterations in T cell subset phenotypes as cell markers for rejection or long-term allograft acceptance in allografted rats treated with antithymocyte globulin. Int Arch Allergy Immunol 1993; 101:431-6.
15. 15 Mjörnstedt L, Olausson M, Hedman L, Lindholm L, Brynger H. Induction of longterm heart allograft survival in the rat by rabbit ATG. Int Arch Allergy Appl Immunol 1984;74:193-9.
16. 16 Olausson M, Mjörnstedt L, Lindholm L, Brynger H. Suppressor cells in the antithymocyte globulin induced transplantation tolerance in the adult rat. Int Arch Allergy Appl Immunol 1984;75:184-7.
17. 17 Hall BM, Pearce NW, Gurley KE, Dorsch SE. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action. J Exp Med 1990;171:141-57.
18. 18 Pearce NW, Berger MF, Gurley KE, Spinelli A, Hall BM. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. VI. In vitro alloreactivity of T cell subsets from rats with long-surviving allografts. Transplantation 1993;55:380-90.
19. 19 Gannedahl G. 15-Deoxyspergualin in experimental and clinical transplantation. Thesis, 1994 University of Uppsala.
20. 20 Spetz-Hagberg AL, Larsson-Sciard EL. Decreased levels of pathogenic IgG anti-DNA antibodies in autoimmune mice after Linomide® treatment. Res Immunol 1989;140:517-25.
21. 21 Larsson EL, Joki A, Stålhandske T. Mechanism of action of the new immunomodulator LS2616 on T cell response. Int J Immunopharmacol 1987;9:425-31.
22. 22 Kalland T, Alm G, Stålhandske T. Augmentation of mouse natural killer cell activity by LS-2616, a new immunomodulator. J Immunol 1985;134:3956-61.
23. 23 Östraat Ö, Riesbeck K. Qi Z et al. Thalidomide prolonged graft survival in a rat cardiac transplant model but had no inhibitory effect on lymphocyte function in vitro. Transpl Immunol 1996;4:117-25.
24. 24 Östraat Ö, Qi Z, Olausson M et al. Mycophenolate mofetil, azathioprine and cyclophosphamide enhanced efficacy combined with cyclosporine in rat cardiac transplantation. Scand J Immunol 1997;45:343-8.
25. 25 Östraat Ö, Qi Z, Tufveson G et al. The effects of leflunomide and cyclosporin A on rejection of cardiac allografts in the rat. Scand J Immunol 1998;47:236-42.
26. 26 Qi Z, Riesbeck K, Östraat Ö et al. Single dose anti-CD4 monoclonal antibody for induction of tolerance to cardiac allograft in high-and low-responder rat strain combinations. Transpl Immunol 1997; 5:204-11.
27. 27 Olausson M, Mjörnstedt L, Lindholm L, Brynger H. Non suture organ grafting to the neck vessels in rats. Acta Chir Scand 1984; 150:463-7.
28. 28 Colton T. Statistics in medicine. Little, Brown and Co., 1974.
29. 29 Stålhandske T, Eriksson E, Sandberg B-M. A novel quinoline-carboximide with interesting immunomodulatory activity. Int J Immunopharmacol 1982;4:336.
30. 30 Wanders A, Gerdin B, Tufveson G. Abolition of the effect of cyclosporine on rat cardiac allograft rejection by the new immunomodulator LS2616 (Linomide®). Transplantation 1989;47:216-7.
31. 31 Gannedahl G, Wanders A, Carlsson M, Tufveson G. 15-deoxyspergualin, effects in rat heart allograft transplantation - relation to dose, timing and cyclosporine. Transplantation 1993;55:455-6.
32. 32 Mjörnstedt L. Olausson M, Lindholm L, Söderström T, Brynger H. Mechanisms maintaining transplantation tolerance in antithymocyte globulin treated rats. Transplantation 1987;44:669-73.
33. 33 Olausson M, Mjörnstedt L, Wramner L, Lindholm L, Söderström T, Brynger H. Characteristics of the induction phase of antithymocyteglobulin induced heart allograft tolerance in the rat. Int Arch Allergy Appl Immunol 1988;86:131-8.
34. 34 Schreiber SL, Crabtree GR. The mechanism of action of cyclo-sporine A and FK506. Immunol Today 1902;13:136.
35. 35 Johansson A, Möller E. Evidence that the immunosuppressive effects of FK506 and cyclosporine are identical. Transplantation 1990;50:1001-7.
36. 36 Tufveson G, Gannedahl G, Johnsson C, Olausson M, Wanders A, Ekberg H. New immunosuppressants: testing and development in animal models and the clinic: with special reference to DSG. Immunol Rev 1993;136:99-109.
37. 37 Wramner L, Mjörnstedt L, Blohmé I, Tufveson G, Söderström T, Olausson M. Alterations of the post-transplant blood lymphocyte phenotype subsets as a marker of rejection in renal allograft recipients. Scand J Immunol 1995;42:275-81.
38. 38 Bourdage JS, Hamlin DM. Comparative polyclonal antithymocyte globulin and antilymphocyte/antilymhoblast globulin anti-cd antigen analysis by flow cytometry. Transplantation 1995;59:1194-200.
39. 39 Merion RM, Howell T, Bromberg JS. Partial T cell activation and anergy induction by polyclonal antithymocyte globulin. Transplantation 1998;65:1481-9.
40. 40 Kilshaw PJ, Brent L, Thomas AV. Specific unresponsiveness to skin allografts in mice. II. The mechanism of unresponsiveness induced by tissue extracts and antilymphocytic serum. Transplantation 1974;17:57-69.
41. 41 Kawai T, Cosimi AB, Colvin RB et al. Mixed allogeneic chimerism and renal allogeneic tolerance in cynomolgus monkeys. Transplantation 1995;59:256-62.